« Return to News | Technology Solutions

StudyManager’s Reveal now features patient registration interface

Friday, February 3, 2012 01:42 PM

StudyManager, a provider of clinical trial management software and electronic data capture solutions, has added a patient registration interface to its Reveal software, enabling research sites, academic medical centers and health systems to integrate Reveal with a variety of electronic health record systems.

Built using HL7 protocols, the new interface increases the efficiency of healthcare providers by automatically synchronizing demographic data for research patients with centralized hospital or clinic records. 

The interface also helps improve patient safety by enabling research staff to more quickly determine whether a patient being recruited for (or treated within) a clinical trial has information stored within the hospital’s electronic health record (EHR) system.  Research staff can then use the EHR to determine whether treatment received within a clinical trial medically conflicts with other treatment received within the health system, or vice-versa.

“Integrating the healthcare delivery enterprise with the clinical research enterprise is an important step in the process of lowering the cost of research for healthcare providers,” said Bruce Schatzman, CEO at StudyManager. “At many institutions, research is not well connected with core healthcare delivery, and this new interface helps eliminate the operational and safety problems this disconnection creates.”

Share:          
CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2012 CenterWatch.